Cargando…
Pharmacokinetics and Anti-Tumor Efficacy of PEGylated Liposomes Co-Loaded with Cisplatin and Mifepristone
Although cisplatin is an effective chemotherapy drug used against many types of cancer, it has poor bioavailability, produces severe adverse effects, and frequently leads to tumor resistance. Consequently, more effective formulations are needed. The co-administration of cisplatin with mifepristone,...
Autores principales: | Ocaña-Arakachi, Karen, Martínez-Herculano, Julio, Jurado, Rafael, Llaguno-Munive, Monserrat, Garcia-Lopez, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609730/ https://www.ncbi.nlm.nih.gov/pubmed/37895808 http://dx.doi.org/10.3390/ph16101337 |
Ejemplares similares
-
Mifepristone Repurposing in Treatment of High-Grade Gliomas
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2021) -
Mifepristone improves chemo-radiation response in glioblastoma xenografts
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2013) -
Liposomes Co-Encapsulating Cisplatin/Mifepristone Improve the Effect on Cervical Cancer: In Vitro and In Vivo Assessment
por: Ledezma-Gallegos, Fabricio, et al.
Publicado: (2020) -
Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2020) -
Corrigendum: Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to Temozolomide
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2021)